XML 36 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity
12 Months Ended
Dec. 31, 2017
Stockholders' Equity  
Stockholders' Equity

13. Stockholders' Equity

Preferred Stock

On June 30, 2015 we redeemed our 3.0 million shares of series A preferred stock for $300.0 million and our 10.0 million shares of series B preferred stock for $250.0 million. At redemption, we recognized $8.2 million excess redemption value over carrying value of the preferred shares redeemed as an adjustment to determine net income available to common stockholders.

On March 30, 2015 and June 30, 2015, we paid a dividend of $8.2 million and $8.3 million, respectively, equal to $1.39 per share on Series A non-cumulative perpetual preferred stock and equal to $0.41 per share on Series B non-cumulative perpetual preferred stock. Dividends were paid to stockholders of record as of March 12, 2015 and June 11, 2015, respectively.

Reconciliation of Outstanding Shares

                                                                                                                                                                                    

 

 

Series A
preferred stock

 

Series B
preferred stock

 

Common
stock

 

 

 

(in millions)

 

Outstanding shares as of January 1, 2015

 

 

3.0

 

 

10.0

 

 

293.9

 

Shares issued

 

 

 

 

 

 

3.5

 

Treasury stock acquired

 

 

 

 

 

 

(6.0

)

Preferred stock redemption

 

 

(3.0

)

 

(10.0

)

 

 

​  

​  

​  

​  

​  

​  

Outstanding shares as of December 31, 2015

 

 

 

 

 

 

291.4

 

Shares issued

 

 

 

 

 

 

3.0

 

Treasury stock acquired

 

 

 

 

 

 

(6.7

)

​  

​  

​  

​  

​  

​  

Outstanding shares as of December 31, 2016

 

 

 

 

 

 

287.7

 

Shares issued

 

 

 

 

 

 

4.9

 

Treasury stock acquired

 

 

 

 

 

 

(3.6

)

​  

​  

​  

​  

​  

​  

Outstanding shares as of December 31, 2017

 

 

 

 

 

 

289.0

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

In February 2014, our Board of Directors authorized a share repurchase program of up to $200.0 million of our outstanding common stock, which was completed in March 2015. In February 2015, our Board of Directors authorized a share repurchase program of up to $150.0 million of our outstanding common stock, which was completed in October 2015. In October 2015, our Board of Directors authorized a share repurchase program of up to $150.0 million of our outstanding common stock, which was completed in March 2016. In February 2016, our Board of Directors authorized a share repurchase program of up to $400.0 million of our outstanding common stock. In May 2017, our Board of Directors authorized a share repurchase program of up to $250.0 million of our outstanding common stock. Shares repurchased under these programs are accounted for as treasury stock, carried at cost and reflected as a reduction to stockholders' equity.

Other Comprehensive Income (Loss)

                                                                                                                                                                                    

 

 

For the year ended
December 31, 2017

 

 

 

Pre-Tax

 

Tax

 

After-Tax

 

 

 

(in millions)

 

Net unrealized gains on available-for-sale securities during the period

 

$

1,074.2

 

$

(341.6

)

$

732.6

 

Reclassification adjustment for losses included in net income (1)

 

 

67.8

 

 

(23.5

)

 

44.3

 

Adjustments for assumed changes in amortization patterns

 

 

(26.2

)

 

9.3

 

 

(16.9

)

Adjustments for assumed changes in policyholder liabilities

 

 

(184.6

)

 

64.1

 

 

(120.5

)

​  

​  

​  

​  

​  

​  

Net unrealized gains on available-for-sale securities

 

 

931.2

 

 

(291.7

)

 

639.5

 

​  

​  

​  

​  

​  

​  

Noncredit component of impairment losses on fixed maturities, available-for-sale during the period

 

 

53.1

 

 

(17.0

)

 

36.1

 

​  

​  

​  

​  

​  

​  

Adjustments for assumed changes in amortization patterns

 

 

(6.4

)

 

2.3

 

 

(4.1

)

Adjustments for assumed changes in policyholder liabilities

 

 

(1.3

)

 

0.5

 

 

(0.8

)

​  

​  

​  

​  

​  

​  

Noncredit component of impairment losses on fixed maturities, available-for-sale (2)

 

 

45.4

 

 

(14.2

)

 

31.2

 

​  

​  

​  

​  

​  

​  

Net unrealized losses on derivative instruments during the period

 

 

(46.7

)

 

16.0

 

 

(30.7

)

Reclassification adjustment for gains included in net income (3)

 

 

(31.6

)

 

10.8

 

 

(20.8

)

Adjustments for assumed changes in amortization patterns

 

 

3.9

 

 

(1.3

)

 

2.6

 

Adjustments for assumed changes in policyholder liabilities

 

 

9.6

 

 

(3.3

)

 

6.3

 

​  

​  

​  

​  

​  

​  

Net unrealized losses on derivative instruments

 

 

(64.8

)

 

22.2

 

 

(42.6

)

​  

​  

​  

​  

​  

​  

Foreign currency translation adjustment during the period

 

 

171.6

 

 

4.7

 

 

176.3

 

Reclassification adjustment for losses included in net income (4)

 

 

2.6

 

 

 

 

2.6

 

​  

​  

​  

​  

​  

​  

Foreign currency translation adjustment

 

 

174.2

 

 

4.7

 

 

178.9

 

​  

​  

​  

​  

​  

​  

Unrecognized postretirement benefit obligation during the period

 

 

24.0

 

 

(3.8

)

 

20.2

 

Amortization of amounts included in net periodic benefit cost (5)

 

 

31.1

 

 

(14.0

)

 

17.1

 

​  

​  

​  

​  

​  

​  

Net unrecognized postretirement benefit obligation

 

 

55.1

 

 

(17.8

)

 

37.3

 

​  

​  

​  

​  

​  

​  

Other comprehensive income

 

$

1,141.1

 

$

(296.8

)

$

844.3

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

                                                                                                                                                                                    

 

 

For the year ended
December 31, 2016

 

 

 

Pre-Tax

 

Tax

 

After-Tax

 

 

 

(in millions)

 

Net unrealized gains on available-for-sale securities during the period

 

$

254.6

 

$

(78.1

)

$

176.5

 

Reclassification adjustment for losses included in net income (1)

 

 

67.9

 

 

(23.5

)

 

44.4

 

Adjustments for assumed changes in amortization patterns

 

 

5.6

 

 

(2.0

)

 

3.6

 

Adjustments for assumed changes in policyholder liabilities

 

 

(177.2

)

 

51.8

 

 

(125.4

)

​  

​  

​  

​  

​  

​  

Net unrealized gains on available-for-sale securities

 

 

150.9

 

 

(51.8

)

 

99.1

 

​  

​  

​  

​  

​  

​  

Noncredit component of impairment losses on fixed maturities, available-for-sale during the period

 

 

(0.3

)

 

(1.5

)

 

(1.8

)

Adjustments for assumed changes in amortization patterns

 

 

(3.4

)

 

1.2

 

 

(2.2

)

Adjustments for assumed changes in policyholder liabilities

 

 

0.8

 

 

(0.3

)

 

0.5

 

​  

​  

​  

​  

​  

​  

Noncredit component of impairment losses on fixed maturities, available-for-sale (2)

 

 

(2.9

)

 

(0.6

)

 

(3.5

)

​  

​  

​  

​  

​  

​  

Net unrealized gains on derivative instruments during the period

 

 

32.6

 

 

(7.6

)

 

25.0

 

Reclassification adjustment for gains included in net income (3)

 

 

(27.7

)

 

5.4

 

 

(22.3

)

Adjustments for assumed changes in amortization patterns

 

 

2.9

 

 

(1.0

)

 

1.9

 

Adjustments for assumed changes in policyholder liabilities

 

 

16.9

 

 

(6.0

)

 

10.9

 

​  

​  

​  

​  

​  

​  

Net unrealized gains on derivative instruments

 

 

24.7

 

 

(9.2

)

 

15.5

 

​  

​  

​  

​  

​  

​  

Foreign currency translation adjustment

 

 

75.6

 

 

(7.5

)

 

68.1

 

​  

​  

​  

​  

​  

​  

Unrecognized postretirement benefit obligation during the period

 

 

20.2

 

 

(6.8

)

 

13.4

 

Amortization of amounts included in net periodic benefit cost (5)

 

 

49.1

 

 

(20.7

)

 

28.4

 

​  

​  

​  

​  

​  

​  

Net unrecognized postretirement benefit obligation

 

 

69.3

 

 

(27.5

)

 

41.8

 

​  

​  

​  

​  

​  

​  

Other comprehensive income

 

$

317.6

 

$

(96.6

)

$

221.0

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

                                                                                                                                                                                    

 

 

For the year ended
December 31, 2015

 

 

 

Pre-Tax

 

Tax

 

After-Tax

 

 

 

(in millions)

 

Net unrealized losses on available-for-sale securities during the period

 

$

(1,713.7

)

$

589.0

 

$

(1,124.7

)

Reclassification adjustment for losses included in net income (1)

 

 

15.1

 

 

(5.4

)

 

9.7

 

Adjustments for assumed changes in amortization patterns

 

 

201.2

 

 

(70.4

)

 

130.8

 

Adjustments for assumed changes in policyholder liabilities

 

 

779.0

 

 

(265.5

)

 

513.5

 

​  

​  

​  

​  

​  

​  

Net unrealized losses on available-for-sale securities

 

 

(718.4

)

 

247.7

 

 

(470.7

)

​  

​  

​  

​  

​  

​  

Noncredit component of impairment losses on fixed maturities, available-for-sale during the period

 

 

29.4

 

 

(10.2

)

 

19.2

 

Adjustments for assumed changes in amortization patterns

 

 

(0.9

)

 

0.3

 

 

(0.6

)

Adjustments for assumed changes in policyholder liabilities

 

 

0.7

 

 

(0.2

)

 

0.5

 

​  

​  

​  

​  

​  

​  

Noncredit component of impairment losses on fixed maturities, available-for-sale (2)

 

 

29.2

 

 

(10.1

)

 

19.1

 

​  

​  

​  

​  

​  

​  

Net unrealized gains on derivative instruments during the period

 

 

58.4

 

 

(20.4

)

 

38.0

 

Reclassification adjustment for gains included in net income (3)

 

 

(36.9

)

 

12.5

 

 

(24.4

)

Adjustments for assumed changes in amortization patterns

 

 

19.5

 

 

(6.9

)

 

12.6

 

Adjustments for assumed changes in policyholder liabilities

 

 

(10.8

)

 

3.8

 

 

(7.0

)

​  

​  

​  

​  

​  

​  

Net unrealized gains on derivative instruments

 

 

30.2

 

 

(11.0

)

 

19.2

 

​  

​  

​  

​  

​  

​  

Foreign currency translation adjustment

 

 

(543.6

)

 

72.0

 

 

(471.6

)

​  

​  

​  

​  

​  

​  

Unrecognized postretirement benefit obligation during the period

 

 

(142.5

)

 

55.5

 

 

(87.0

)

Amortization of amounts included in net periodic benefit cost (5)

 

 

81.2

 

 

(33.3

)

 

47.9

 

​  

​  

​  

​  

​  

​  

Net unrecognized postretirement benefit obligation

 

 

(61.3

)

 

22.2

 

 

(39.1

)

​  

​  

​  

​  

​  

​  

Other comprehensive loss

 

$

(1,263.9

)

$

320.8

 

$

(943.1

)

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  


(1)          

Pre-tax reclassification adjustments relating to available-for-sale securities are reported in net realized capital gains (losses) on the consolidated statements of operations.

(2)          

Represents the net impact of (1) unrealized gains resulting from reclassification of previously recognized noncredit impairment losses from OCI to net realized capital gains (losses) for fixed maturities with bifurcated OTTI that had additional credit losses or fixed maturities that previously had bifurcated OTTI that have now been sold or are intended to be sold and (2) unrealized losses resulting from reclassification of noncredit impairment losses for fixed maturities with bifurcated OTTI from net realized capital gains (losses) to OCI.

(3)          

See Note 5, Derivative Financial Instruments — Cash Flow Hedges, for further details.

(4)          

Pre-tax reclassification adjustments relating to deconsolidated sponsored investment funds are reported in net realized capital gains (losses) on the consolidated statements of operations. $2.0 million of this reclassification relates to noncontrolling interest and is reported in net income attributable to noncontrolling interest on the consolidated statements of operations.

(5)          

Amount is comprised of amortization of prior service cost (benefit) and recognized net actuarial (gain) loss, which is reported in operating expenses on the consolidated statements of operations. See Note 11, Employee and Agent Benefits — Components of Net Periodic Benefit Cost, for further details.

Accumulated Other Comprehensive Income (Loss)

                                                                                                                                                                                    

 

 

Net unrealized
gains on
available-for-sale
securities

 

Noncredit
component of
impairment losses
on fixed maturities
available-for-sale

 

Net unrealized
gains
on derivative
instruments

 

Foreign
currency
translation
adjustment

 

Unrecognized
postretirement
benefit
obligation

 

Accumulated
other
comprehensive
income (loss)

 

 

 

(in millions)

 

Balances as of January 1, 2015

 

$

1,202.8

 

$

(105.1

)

$

50.6

 

$

(686.8

)

$

(411.1

)

$

50.4

 

Other comprehensive loss during the period, net of adjustments

 

 

(480.4

)

 

 

 

43.6

 

 

(451.1

)

 

(87.0

)

 

(974.9

)

Amounts reclassified from AOCI

 

 

9.7

 

 

19.1

 

 

(24.4

)

 

 

 

47.9

 

 

52.3

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Other comprehensive loss

 

 

(470.7

)

 

19.1

 

 

19.2

 

 

(451.1

)

 

(39.1

)

 

(922.6

)

Purchase of subsidiary shares from noncontrolling interest

 

 

 

 

 

 

 

 

(10.3

)

 

 

 

(10.3

)

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Balances as of December 31, 2015

 

 

732.1

 

 

(86.0

)

 

69.8

 

 

(1,148.2

)

 

(450.2

)

 

(882.5

)

Other comprehensive income during the period, net of adjustments

 

 

54.7

 

 

(3.5

)

 

37.8

 

 

63.7

 

 

13.4

 

 

166.1

 

Amounts reclassified from AOCI

 

 

44.4

 

 

 

 

(22.3

)

 

 

 

28.4

 

 

50.5

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Other comprehensive income

 

 

99.1

 

 

(3.5

)

 

15.5

 

 

63.7

 

 

41.8

 

 

216.6

 

Purchase of subsidiary shares from noncontrolling interest

 

 

 

 

 

 

 

 

(9.3

)

 

 

 

(9.3

)

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Balances as of December 31, 2016

 

 

831.2

 

 

(89.5

)

 

85.3

 

 

(1,093.8

)

 

(408.4

)

 

(675.2

)

Other comprehensive income during the period, net of adjustments

 

 

595.2

 

 

 

 

(21.8

)

 

174.7

 

 

20.2

 

 

768.3

 

Amounts reclassified from AOCI

 

 

44.3

 

 

31.2

 

 

(20.8

)

 

0.6

 

 

17.1

 

 

72.4

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Other comprehensive income

 

 

639.5

 

 

31.2

 

 

(42.6

)

 

175.3

 

 

37.3

 

 

840.7

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Balances as of December 31, 2017

 

$

1,470.7

 

$

(58.3

)

$

42.7

 

$

(918.5

)

$

(371.1

)

$

165.5

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Noncontrolling Interest

Interests held by unaffiliated parties in consolidated entities are reflected in noncontrolling interest, which represents the noncontrolling partners' share of the underlying net assets of our consolidated subsidiaries. Noncontrolling interest that is not redeemable is reported in the equity section of the consolidated statements of financial position.

The noncontrolling interest holders in certain of our consolidated entities maintain an equity interest that is redeemable at the option of the holder, which may be exercised on varying dates. Since redemption of the noncontrolling interest is outside of our control, this interest is presented on the consolidated statements of financial position line item titled "Redeemable noncontrolling interest." Our redeemable noncontrolling interest primarily relates to consolidated sponsored investment funds for which interests are redeemed at fair value from the net assets of the funds.

For our redeemable noncontrolling interest related to other consolidated subsidiaries, redemptions are required to be purchased at fair value or a value based on a formula that management intended to reasonably approximate fair value based on a fixed multiple of earnings over a measurement period. The carrying value of the redeemable noncontrolling interest is compared to the redemption value at each reporting period. Any adjustments to the carrying amount of the redeemable noncontrolling interest for changes in redemption value prior to exercise of the redemption option are determined after the attribution of net income or loss of the subsidiary and are recognized in the redemption value as they occur. Adjustments to the carrying value of redeemable noncontrolling interest result in adjustments to additional paid-in capital and/or retained earnings. Adjustments are recorded in retained earnings to the extent the redemption value of the redeemable noncontrolling interest exceeds its fair value and will impact the numerator in our earnings per share calculations. All other adjustments to the redeemable noncontrolling interest are recorded in additional paid-in capital.

Following is a reconciliation of the changes in the redeemable noncontrolling interest (in millions):

                                                                                                                                                                                    

Balance as of January 1, 2015

 

$

58.0

 

Net income attributable to redeemable noncontrolling interest

 

 

4.9

 

Contributions from redeemable noncontrolling interest

 

 

56.1

 

Distributions to redeemable noncontrolling interest

 

 

(15.1

)

Purchase of subsidiary shares from redeemable noncontrolling interest

 

 

(6.0

)

Change in redemption value of redeemable noncontrolling interest

 

 

6.6

 

Other comprehensive income attributable to redeemable noncontrolling interest

 

 

(18.8

)

​  

​  

Balance as of December 31, 2015

 

 

85.7

 

Net income attributable to redeemable noncontrolling interest

 

 

16.8

 

Redeemable noncontrolling interest of newly consolidated entities (1)

 

 

179.5

 

Redeemable noncontrolling interest of deconsolidated entities (2)

 

 

(261.5

)

Contributions from redeemable noncontrolling interest

 

 

135.1

 

Distributions to redeemable noncontrolling interest

 

 

(57.4

)

Purchase of subsidiary shares from redeemable noncontrolling interest

 

 

(8.2

)

Change in redemption value of redeemable noncontrolling interest

 

 

4.2

 

Other comprehensive income attributable to redeemable noncontrolling interest

 

 

3.3

 

​  

​  

Balance as of December 31, 2016

 

 

97.5

 

Net income attributable to redeemable noncontrolling interest

 

 

7.0

 

Redeemable noncontrolling interest of deconsolidated entities (2)

 

 

(61.1

)

Contributions from redeemable noncontrolling interest

 

 

94.1

 

Distributions to redeemable noncontrolling interest

 

 

(39.0

)

Purchase of subsidiary shares from redeemable noncontrolling interest

 

 

(4.4

)

Change in redemption value of redeemable noncontrolling interest

 

 

5.9

 

Other comprehensive income attributable to redeemable noncontrolling interest

 

 

1.3

 

​  

​  

Balance as of December 31, 2017

 

$

101.3

 

​  

​  

​  

​  


(1)          

Effective January 1, 2016, certain sponsored investment funds were consolidated as a result of the implementation of new accounting guidance.

(2)          

We deconsolidated certain sponsored investment funds as they no longer met the requirements for consolidation.

Dividend Limitations

The declaration and payment of our common stock dividends is subject to the discretion of our Board of Directors and will depend on our overall financial condition, results of operations, capital levels, cash requirements, future prospects, receipt of dividends from Principal Life (as described below), risk management considerations and other factors deemed relevant by the Board. No significant restrictions limit the payment of dividends by us, except those generally applicable to corporations incorporated in Delaware.

Under Iowa law, Principal Life may pay stockholder dividends only from the earned surplus arising from its business and must receive the prior approval of the Commissioner of Insurance of the State of Iowa (the "Commissioner") to pay a stockholder dividend if such a stockholder dividend would exceed certain statutory limitations. In general, the current statutory limitation is the greater of 10% of Principal Life's policyholder surplus as of the preceding year-end or the net gain from operations from the previous calendar year. Based on this limitation and 2017 statutory results, Principal Life could pay approximately $1,122.4 million in ordinary stockholder dividends in 2018 without prior regulatory approval. However, because the dividend test is based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2018, some or all of such dividends may be extraordinary and require regulatory approval.

On May 1, 2017, Principal Life sold its ownership interest in Principal Global Investors, LLC to Principal Life's direct parent, Principal Financial Services, Inc. in connection with a corporate reorganization designed to better utilize and allocate capital internally. Subsequent to the sale, Principal Life paid an extraordinary dividend of $1,068.4 million to its parent, which was approved by the Commissioner, primarily from proceeds received from the sale.